Related Experiment Videos
Prion protein gene expression in cultured cells
M R Scott1, D A Butler, D E Bredesen
1Department of Neurology, University of California, San Francisco 94143.
Protein Engineering
|April 1, 1988
Summary
Researchers investigated prion protein (PrP) expression in cell lines. They found that while PrP mRNA levels were normal, PrP protein levels were very low, suggesting post-transcriptional regulation is crucial for PrP expression.
Area of Science:
- Molecular Biology
- Neuroscience
- Biochemistry
Background:
- The prion protein (PrP) exists in two isoforms: cellular (PrPC) and scrapie (PrPSc).
- PrPSc is associated with transmissible spongiform encephalopathies like scrapie.
- Understanding PrP expression is key to understanding these diseases.
Purpose of the Study:
- To investigate the expression levels of PrP in cultured cell lines.
- To determine if cell lines can be used to study PrP processing and function.
- To explore methods for achieving higher PrP expression in vitro.
Main Methods:
- Cultured cell lines were analyzed for endogenous PrP mRNA and protein levels.
- Transfection experiments using expression vectors with strong eukaryotic promoters were performed.
- High-level PrP expression was induced using baculovirus and SV40-based vectors.
Main Results:
- Cultured cells showed PrP mRNA levels comparable to rodent brains but significantly reduced PrP protein levels, often undetectable by Western immunoblot.
- Transfection with standard expression vectors did not lead to elevated PrP expression.
- High-level expression using baculovirus or SV40 vectors produced PrP, but with altered processing compared to brain PrPC.
- SV40 vector-expressed PrP showed cell surface transport, while baculovirus-expressed PrP did not induce scrapie in hamsters.
Conclusions:
- Cultured cell lines exhibit post-transcriptional regulation of PrP expression.
- Mammalian expression systems like the SV40 late promoter vector show promise for studying PrPSc roles and PrPC function.
- Further research is needed to fully understand PrP processing and its implications in prion diseases.